BioCardia (BCDA) EPS (Basic) Growth (1y) (2017 - 2026)
Powered by 
Analysis
BioCardia (BCDA) EPS (Basic) Growth (1y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 39.88% |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 68.53% |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 162.14% |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -102.31% |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 515.34% |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | 66.89% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.89% |
| Mar 31, 2026 | 64.36% |
| Sep 30, 2025 | 61.83% |
| Jun 30, 2025 | 53.86% |
| Mar 31, 2025 | 56.69% |
| Dec 31, 2024 | 10.58% |
| Sep 30, 2024 | 65.55% |
| Jun 30, 2024 | 65.41% |
| Mar 31, 2024 | 47.97% |
| Dec 31, 2023 | 42.22% |
| Sep 30, 2023 | 29.91% |
| Jun 30, 2023 | -19.76% |
| Mar 31, 2023 | 10.77% |
| Dec 31, 2022 | 16.73% |
| Sep 30, 2022 | -8.15% |
| Jun 30, 2022 | 30.87% |
| Mar 31, 2022 | -8.69% |
| Dec 31, 2021 | 40.82% |
| Sep 30, 2021 | 48.01% |
| Jun 30, 2021 | 55.85% |